000 01629 a2200445 4500
005 20250511230022.0
264 0 _c19900926
008 199009s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19900901)66:5<862::aid-cncr2820660509>3.0.co;2-r
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorden, E C
245 0 0 _aRandomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.
_h[electronic resource]
260 _bCancer
_cSep 1990
300 _a862-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNausea
_xchemically induced
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRemission Induction
650 0 4 _aSarcoma
_xdrug therapy
650 0 4 _aSoft Tissue Neoplasms
_xdrug therapy
650 0 4 _aVindesine
_xadministration & dosage
650 0 4 _aVomiting
_xchemically induced
700 1 _aAmato, D A
700 1 _aEdmonson, J H
700 1 _aRitch, P S
700 1 _aShiraki, M
773 0 _tCancer
_gvol. 66
_gno. 5
_gp. 862-7
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19900901)66:5<862::aid-cncr2820660509>3.0.co;2-r
_zAvailable from publisher's website
999 _c2207555
_d2207555